Prostaglandins in peptic ulcer disease

References

• Robert A, Nezamis JE, Phillips JP. Inhibition of gastric secretion by prostaglandins. Dig Dis Sci 1967: 12(10): 1073–6
   Web of Science ®Google Scholar
• Wilson DE, Phillips C, Levine RA. Inhibition of gastric secretion in man by prostaglandin A. Gastroenterology 1971:61(2): 201–6
   PubMed Web of Science ®Google Scholar
• Lippmann W. Inhibition of gastric acid secretion by a potent synthetic prostaglandin. J Pharm Pharmacol 1970:22(1): 65–7
   PubMed Web of Science ®Google Scholar
• Karim SM, Carter DC. Bhana D, et al. Effect of orally administered prostaglandin E2 and its 15-methyl analogues on gastric secretion. Br Med J 1973: 1(846): 143–6
   PubMedGoogle Scholar
• Wilson DE, Winnan G, Quertermus J, et al. Effects of an orally administered prostaglandin analogue (16,16-dimethyl prostaglandin E2) on human gastric secretion. Gastroenterology 1975:69(3): 607–11
   PubMed Web of Science ®Google Scholar
• Bauer RF, Kessler LK, Tsai BS. Identification of E-type prostaglandin receptors on isolated parietal cells using [3H] misoprostol free acid. Am J Med (in press)
   Google Scholar
• Robert A. Antisecretory property of prostaglandins. In: Proceedings of Prostaglandin Symposium of the Worcester Foundation for Experimental Biology, Oct 16–17, 1967. New York: Wiley-Interecience, 1968: 47–54
   Google Scholar
• Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Leukotriene Res 1976: 2: 507–20
   PubMedGoogle Scholar
• Robert A, Nezamis JE, Lancaster C, et al. Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol, HCL, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979: 77(3): 433–43
   PubMed Web of Science ®Google Scholar
• Lancaster C, Robert A. Intestinal lesions produced by prednisolone: prevention(cytoprotection)by 16.16-dimethyl prostaglandin E2. AmJ Physiol 1978: 236(6): E703–8
   Google Scholar
• Davenport HW. Back diffusion of add through the gastric mucosa and its physiological consequence. Prog Gastroenterol 1970: 11: 42–56
   Google Scholar
• Dajani EZ, Callison DA, Bertermann RE. Effects of E prostaglandins on canine gastric potential difference. Dig Dis Sci 1978: 23(5): 436–42
   Web of Science ®Google Scholar
• Chaudhury TK, Jacobson ED. Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 1978: 74(1): 58–63
   PubMed Web of Science ®Google Scholar
• Robert A, Lancaster C, Davis JP, et al. Cytoprotection by prostaglandin occurs in spite of penetration of absolute ethanol into the gastric mucosa. Gastroenterology 1985: 88(1 Pt 2): 328–33
   PubMed Web of Science ®Google Scholar
• Isenberg JI, Smedfors B, Johansson C. Effect of graded doses of intraluminal H+, prostaglandin E2, and inhibition of endogenous prostaglandin synthesis on proximal duodenal bicarbonate secretion in unanesthetized rat. Gastroenterology 1985:88(1 Pt 2): 303–7
   PubMed Web of Science ®Google Scholar
• Selling JA, Hogan DL, Koss MA, et al. Human proximal versus distal duodenal bicarbonate secretion. Gastroenterology 1985: 88(5 Pt 2): 1580
   Web of Science ®Google Scholar
• Tao P, Wilson DE. Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume, (H +) and mucus synthesis and secretion in the rat. Prostaglandins 1984: 28(3): 353–65
   PubMed Web of Science ®Google Scholar
• Johansson C, Kollberg B. Stimulation by intragastrically administered E2 prostaglandins of human gastric mucus output. Eur J Clin Invest 1979: 9(3): 229–32
   PubMed Web of Science ®Google Scholar
• Kaymakcalan H, Ramsamooj E, Wilson DE. The effect of a novel prostaglandin (PG)E1 analogue (CL 115,574) on gastric acid and mucus secretion in man. Prostaglandins 1984:28(1): 5–12
   PubMedGoogle Scholar
• Takeuchi K, Magee D, Critchlow J, et al. Studies of the pH gradient and thickness of froggastric mucus gel. Gastroenterology 1983:84(2): 331–40
   PubMed Web of Science ®Google Scholar
• McQueen S, Allen A, Garner A. Measurement of gastric and duodenal mucus gel thickness. In: Allen A. Flemström G. Gamer A, et al, eds. Mechanisms of mucosal protection in the upper gastrointestinal tract. New York: Raven Press, 1984: 215–22
   Google Scholar
• Kivilaakso E, Flemstron G. Surface pH gradient and prostaglandin cytoprotection in gastroduodenal mucosa. In: Allen et al, eds,21 pp 227–32
   Google Scholar
• Whittle BJ, Kauffman GL, Moncada S. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature 1981: 292(5822): 472–4
   PubMed Web of Science ®Google Scholar
• Whittle BJ. Cellular mediators in gastric damage: actions of thromboxane A2 and its inhibitors. In: Allen et al, eds,21 pp 295–302
   Google Scholar
• Sato N, Kawano S, Fukado M. The effect of misoprostol on gastric mucosal hemodynamics in man: a possible mechanism of cytoprotection. Am J Med (in press)
   Google Scholar
• Szabo S, Trier JS, Brown A, et al. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1985: 88(1 Pt 2): 228–36
   PubMed Web of Science ®Google Scholar
• Ito S, Lacy ER. Morphology of rat gastric mucosal damage, defense, and restitution in the presence of luminal ethanol. Gastroenterology 1985: 88(1 Pt 2): 250–60
   PubMed Web of Science ®Google Scholar
• Tarnawski A, Hollander D, Stachura J, et al. Prostaglandin protection of the gastric mucosa against alcohol Injury—a dynamic time-related process: role of the mucosal proliferative zone. Gastroenterology 1985: 88(1 Pt 2): 334–52
   PubMed Web of Science ®Google Scholar
• Dupuy D, Szabo S. Protection by metals against ethanol-induced gastric mucosal injury in the rat: comparative biochemical and pharmacologic studies implicate protein sulfhydryls. Gastroenterology 1986: 91(4): 966–74
   PubMed Web of Science ®Google Scholar
• Gibinsky K, Rybicka J, Mikos E, et al. Doubleblind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues. Gut 1977: 18(8): 636–9
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Janssens J, Popiela T, et al. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study. Gastroenterology 1982: 83(2): 357–63
   PubMed Web of Science ®Google Scholar
• Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol and Cimetidine in the treatment of duodenal ulcers in out-patients. Dig Dis Sci 1985: 30(11 Suppl): 171–7S
   Web of Science ®Google Scholar
• Rachmilewitz D, Chapman JW, Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol with Cimetidine in treatment of gastric ulcer in outpatients. Dig Dis Sci 1986: 31 (2 Suppl): 75–80S
   Web of Science ®Google Scholar
• Bardhan KD. Refractory duodenal ulcer. Gut 1984: 25(7): 711–7
   PubMed Web of Science ®Google Scholar
• Sontag S, Graham DY, Belsito A, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med 1984: 311(11): 689–93
   PubMed Web of Science ®Google Scholar
• Lam SK, Lau WY, Choi TK, et al. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Dig Dis Sci 1986: 31(2 Suppl): 68–74S
   Web of Science ®Google Scholar
• Quimby GF, Bonnice CA, Burstein SH, et al. Active smoking depresses prostaglandin synthesis in human gastric mucosa. Ann Intern Med 1986: 104(5): 616–9
   PubMed Web of Science ®Google Scholar
• Pemberton RE, Stran LJ. A review of uppergastrointestinal effects of the newer nonsteroidal antiinflammatory agents. Dig Dis Sci 1979: 24(1): 53–64
   PubMed Web of Science ®Google Scholar
• Johansson C, Kollberg B, Nordemar R, et al. Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology 1980:78(3): 479–83
   PubMed Web of Science ®Google Scholar
• Cohen MM. Use of prostaglandins to reduce gastroduodenal injury with nonsteroidal antiinflammatory drugs. Intern Med Specialist 1984: 5: 75–87
   Google Scholar
• Lanza FL. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci 1986: 31(2 Suppl): 131–6S
   PubMed Web of Science ®Google Scholar
• Agrawal NM, Godiwala T, Arimura A, et al. Comparative cytoprotective effects against alcohol insult: misoprostol versus Cimetidine. Dig Dis Sci 1986: 31(2 Suppl): 142S
   PubMed Web of Science ®Google Scholar
• Hinsdale JG. Engel JJ, Ivey KJ, et al. Prostaglandin E in peptic ulcer disease. Prostaglandins 1975: 6: 495–500
   Web of Science ®Google Scholar
• Ahlquist DA, Dozois RR, Zinsmeister AR, et al. Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. Gastroenterology 1983:85(3): 522–8
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Branski D, Sharon P, et al. Possible role of endogenous prostanoids in the pathogenesis of peptic ulcer. In: Allen et al, eds,21 pp 329–33
   Google Scholar